GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (STU:NXE0) » Definitions » Deferred Policy Acquisition Costs

Seelos Therapeutics (STU:NXE0) Deferred Policy Acquisition Costs


View and export this data going back to 2010. Start your Free Trial

What is Seelos Therapeutics Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Seelos Therapeutics (STU:NXE0) Business Description

Industry
Traded in Other Exchanges
Address
300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.